Monsanto has completed a earlier this year evaluation of NRGene 's GenoMAGICTM data analytics platform , and expressed satisfaction with its ability to support the German company's genomics-based molecular breeding pipeline. Following successful evaluation, Bayer has chosen the GenoMAGICTM platform to support its advanced molecular breeding program in several key crops Ness Ziona, Israel – (December 3, 2018) –NRGene, the worldwide leader in genomic analysis, announces a key milestone in its multi-year licensing agreement with Bayer for the use of GenoMAGICTM, a cloud-based big data analytics platform to support the company’s molecular breeding program within its Crop Science Division. Cloud-based Bayer expands Bayer 's ability to discover traits and to enhance genomes. It's also good for genomic selection and will be used on some of the firm's key crops. NRGene signed a licensing agreement with Bayer prior to its acquisition by Bayer year-long .
Monsanto has completed a earlier this year evaluation of NRGene 's GenoMAGICTM data analytics platform , and expressed satisfaction with its ability to support the German company's genomics-based molecular breeding pipeline. Cloud-based Bayer expands Bayer 's ability to discover traits and to enhance genomes. It's also good for genomic selection and will be used on some of the firm's key crops. NRGene signed a licensing agreement with Bayer prior to its acquisition by Bayer year-long .